RISK STRATIFICATION AND PATIENT COUNSELING FOR NATALIZUMAB IN MULTIPLE SCLEROSIS

被引：38
|
作者：
Fox, Robert J. [1 ]
Rudick, Richard A.
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44106 USA
来源：
NEUROLOGY | 2012年 / 78卷 / 06期
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
D O I：
10.1212/WNL.0b013e318245d2d0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [1] Natalizumab: Risk Stratification of Individual Patients with Multiple Sclerosis
    Carmen Tur
    Xavier Montalban
    CNS Drugs, 2014, 28 : 641 - 648
  • [2] Natalizumab: Risk Stratification of Individual Patients with Multiple Sclerosis
    Tur, Carmen
    Montalban, Xavier
    CNS DRUGS, 2014, 28 (07) : 641 - 648
  • [3] Risk stratification for progressive multifocal leukoencephalopathy in multiple sclerosis patients using natalizumab
    Sandrock, A.
    Hotermans, C.
    Richman, S.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Bloomgren, G.
    Subramanyam, M.
    Bozic, C.
    JOURNAL OF NEUROLOGY, 2011, 258 : 23 - 23
  • [4] Review on PML Risk Stratification in Natalizumab-Treated Multiple Sclerosis Patients
    Grigoriadis, Nikolaos C.
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 61 - 63
  • [5] Multiple Sclerosis Natalizumab: Efficacy with risk
    Diener, H. C.
    Hecht, Birgit
    PSYCHOPHARMAKOTHERAPIE, 2010, 17 (02): : 106 - 108
  • [6] Morphea in a Multiple Sclerosis Patient Treated with Natalizumab
    Alikhani, Katayoun
    Kremenchutzky, Marcelo
    NEUROLOGY, 2010, 74 (09) : A418 - A419
  • [7] Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
    Prezioso, Carla
    Zingaropoli, Maria Antonella
    Iannetta, Marco
    Rodio, Donatella Maria
    Altieri, Marta
    Conte, Antonella
    Vullo, Vincenzo
    Ciardi, Maria Rosa
    Palamara, Anna Teresa
    Pietropaolo, Valeria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [8] Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab
    Valenzuela, Reuben Mari
    Pula, John H.
    Garwacki, Dennis
    Cotter, John
    Kattah, Jorge C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 109 - 111
  • [9] UNUSUAL DETERIORATION IN A PATIENT WITH MULTIPLE SCLEROSIS ON NATALIZUMAB THERAPY
    Gattringer, Thomas
    Enzinger, Christian
    Khalil, Michael
    Schwingenschuh, Petra
    Pichler, Alexander
    Moser, Alexander
    Graninger, Winfried
    Ernst, Christina
    Haybaeck, Johannes
    Fazekas, Franz
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (01):
  • [10] Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab
    Durrieu, Genevieve
    Dardonville, Quentin
    Clanet, Michel
    Montastruc, Jean-Louis
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (01) : 125 - 126
12345